This report includes an overview of Duchenne and Becker muscular dystrophies, their management and genetic aspects. This is followed by a discussion of the diagnosis-and-screening strategy, the test validity, and various aspects of the Quebec context. Lastly the social and ethical issues raised by these new technologies are explored.